Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In vivo, Ex-4 has been demonstrated to inhibit prostate cancer cell growth by activating GLP-1R, reducing s-phase kinase-associated protein-2 (SKP2) gene expression, subsequently increasing p27Kip1 (p27) protein levels, and inducing tumor cell cycle arrest [67]
It has been released and is available now
2017, p
Third, our modelling incorporated projected uptake scenarios, enhancing the practical relevance of our findings
M., & Kesek, A
.jpg)
.png)
US$ 26.86
US$ 26.31
US$ 22.60
US$ 23.90
